Argent Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-145,357	Closed	-$30M	–	155
2024 Q2	$30M	Sell	145,357 -1,895	-1%	-$429K	0.88%	37
2024 Q1	$39.9M	Buy	147,252 +85,300	+138%	+$20.4M	1.16%	32
2023 Q4	$14.6M	Sell	61,952 -93,821	-60%	-$18.5M	0.48%	52
2023 Q3	$30.5M	Sell	155,773 -12,617	-7%	-$2.59M	1.09%	33
2023 Q2	$35.4M	Sell	168,390 -3,779	-2%	-$752K	1.15%	33
2023 Q1	$34.7M	Buy	172,169 +1,938	+1%	+$439K	1.2%	35
2022 Q4	$37.1M	Buy	170,231 +780	+0.5%	+$170K	1.33%	29
2022 Q3	$33.3M	Buy	169,451 +158,627	+1,466%	+$34.2M	1.31%	28
2022 Q2	$2.32M	Sell	10,824 -134	-1%	-$32.7K	0.09%	83
2022 Q1	$3.11M	Buy	10,958 +110	+1%	+$33.9K	0.1%	74
2021 Q4	$4.09M	Buy	10,848 +176	+2%	+$68.4K	0.12%	71
2021 Q3	$4.4M	Buy	10,672 +182	+2%	+$75.6K	0.14%	64
2021 Q2	$3.88M	Buy	10,490 +570	+6%	+$190K	0.12%	69
2021 Q1	$2.88M	Buy	9,920 +36	+0.4%	+$10K	0.1%	77
2020 Q4	$2.47M	Buy	9,884 +1,092	+12%	+$260K	0.09%	79
2020 Q3	$1.99M	Buy	8,792 +911	+12%	+$189K	0.08%	80
2020 Q2	$1.37M	Buy	+7,881	New	+$1.26M	0.06%	99